The development of an innovative drug is a complex process. It begins with the identification of lead compounds, the screening of active substances in pre-clinical and clinical studies and leads to the approval of novel drugs. The average duration of this process is 10 to 15 years and requires profound knowledge, technologies and methods.
The institutes and medical centers of the University of Frankfurt/ Main can cover almost any aspect of this value chain. This wealth of knowledge is combined in ZAFES and results in the efficient and competent handling of scientific questions, a development which benefits the university, industry and biotechnology.